Editas Medicine (EDIT) Assets Average (2016 - 2025)

Editas Medicine (EDIT) has 10 years of Assets Average data on file, last reported at $194.1 million in Q4 2025.

• Quarterly Assets Average fell 41.97% year-over-year to $194.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $194.1 million (down 41.97% YoY) and the FY2025 annual result came in at $264.1 million, down 37.18% from the prior year.
• Assets Average eased to $194.1 million in Q4 2025 per EDIT's latest filing, from $206.2 million in the prior quarter.
• Across five years, Assets Average topped out at $768.1 million in Q2 2021 and bottomed at $194.1 million in Q4 2025.
• The 5-year median for Assets Average is $502.5 million (2023), against an average of $487.0 million.
• The widest annual swing landed in 2021, when Assets Average surged 38.67%; it then slumped 42.53% in 2025.
• Tracing EDIT's Assets Average over 5 years: stood at $697.3 million in 2021, then slipped by 25.04% to $522.7 million in 2022, then decreased by 3.97% to $501.9 million in 2023, then tumbled by 33.34% to $334.6 million in 2024, then plunged by 41.97% to $194.1 million in 2025.
• Per Business Quant, the three latest EDIT Assets Average figures stand at $194.1 million (Q4 2025), $206.2 million (Q3 2025), and $237.1 million (Q2 2025).

Peer Comparison